Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CEY
VictoryShares Emerging Market High Div Volatility Wtd ETF
$18.58
$18.58
$16.07
$24.93
$9.29MN/A3,875 shs31,600 shs
ELD
WisdomTree Emerging Markets Local Debt Fund
$26.91
+0.1%
$27.19
$25.01
$28.59
$80.73M0.3915,909 shs5,408 shs
Sasol Limited stock logo
SSL
Sasol
$7.23
+0.1%
$7.73
$6.74
$14.49
$4.59B2.42673,034 shs405,029 shs
10x Genomics, Inc. stock logo
TXG
10x Genomics
$25.36
-3.0%
$35.02
$24.60
$63.57
$3.02B1.941.56 million shs1.66 million shs
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
CEY
VictoryShares Emerging Market High Div Volatility Wtd ETF
0.00%0.00%0.00%0.00%0.00%
ELD
WisdomTree Emerging Markets Local Debt Fund
+0.15%+1.60%-2.18%-1.97%-0.96%
Sasol Limited stock logo
SSL
Sasol
+0.14%+4.18%-17.37%-11.07%-42.80%
10x Genomics, Inc. stock logo
TXG
10x Genomics
-2.98%-5.79%-30.52%-47.68%-52.36%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
CEY
VictoryShares Emerging Market High Div Volatility Wtd ETF
N/AN/AN/AN/AN/AN/AN/AN/A
ELD
WisdomTree Emerging Markets Local Debt Fund
N/AN/AN/AN/AN/AN/AN/AN/A
Sasol Limited stock logo
SSL
Sasol
2.8776 of 5 stars
0.04.01.70.01.00.03.8
10x Genomics, Inc. stock logo
TXG
10x Genomics
4.4308 of 5 stars
4.31.00.04.81.63.30.6

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
CEY
VictoryShares Emerging Market High Div Volatility Wtd ETF
0.00
N/AN/AN/A
ELD
WisdomTree Emerging Markets Local Debt Fund
0.00
N/AN/AN/A
Sasol Limited stock logo
SSL
Sasol
2.00
HoldN/AN/A
10x Genomics, Inc. stock logo
TXG
10x Genomics
2.58
Moderate Buy$48.5091.25% Upside

Current Analyst Ratings

Latest CEY, SSL, TXG, and ELD Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/1/2024
10x Genomics, Inc. stock logo
TXG
10x Genomics
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$52.00 ➝ $30.00
5/1/2024
10x Genomics, Inc. stock logo
TXG
10x Genomics
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetSell ➝ Sell$30.00 ➝ $26.00
5/1/2024
10x Genomics, Inc. stock logo
TXG
10x Genomics
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$45.00 ➝ $36.00
5/1/2024
10x Genomics, Inc. stock logo
TXG
10x Genomics
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$63.00 ➝ $53.00
5/1/2024
10x Genomics, Inc. stock logo
TXG
10x Genomics
TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Hold$57.00 ➝ $32.00
4/29/2024
10x Genomics, Inc. stock logo
TXG
10x Genomics
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$65.00 ➝ $50.00
4/18/2024
10x Genomics, Inc. stock logo
TXG
10x Genomics
Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$60.00 ➝ $55.00
4/10/2024
10x Genomics, Inc. stock logo
TXG
10x Genomics
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$55.00 ➝ $45.00
2/16/2024
10x Genomics, Inc. stock logo
TXG
10x Genomics
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$68.00 ➝ $63.00
(Data available from 5/9/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
CEY
VictoryShares Emerging Market High Div Volatility Wtd ETF
N/AN/AN/AN/AN/AN/A
ELD
WisdomTree Emerging Markets Local Debt Fund
N/AN/AN/AN/AN/AN/A
Sasol Limited stock logo
SSL
Sasol
$16.30B0.28$4.58 per share1.58$17.92 per share0.40
10x Genomics, Inc. stock logo
TXG
10x Genomics
$618.73M4.88N/AN/A$6.22 per share4.08

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
CEY
VictoryShares Emerging Market High Div Volatility Wtd ETF
N/AN/A0.00N/AN/AN/AN/AN/A
ELD
WisdomTree Emerging Markets Local Debt Fund
N/AN/A0.00N/AN/AN/AN/AN/A
Sasol Limited stock logo
SSL
Sasol
$496.26MN/A0.002.470.28N/AN/AN/AN/A
10x Genomics, Inc. stock logo
TXG
10x Genomics
-$255.10M-$2.23N/AN/AN/A-42.20%-30.85%-24.17%8/1/2024 (Estimated)

Latest CEY, SSL, TXG, and ELD Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/30/2024Q1 2024
10x Genomics, Inc. stock logo
TXG
10x Genomics
-$0.50-$0.50N/A-$0.50$142.24 million$141.01 million    
2/15/2024Q4 2023
10x Genomics, Inc. stock logo
TXG
10x Genomics
-$0.36-$0.41-$0.05-$0.41$182.73 million$183.98 million    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
CEY
VictoryShares Emerging Market High Div Volatility Wtd ETF
$1.105.92%N/AN/AN/A
ELD
WisdomTree Emerging Markets Local Debt Fund
$1.365.05%N/AN/AN/A
Sasol Limited stock logo
SSL
Sasol
$0.172.35%N/AN/AN/A
10x Genomics, Inc. stock logo
TXG
10x Genomics
N/AN/AN/AN/AN/A

Latest CEY, SSL, TXG, and ELD Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/26/2024
Sasol Limited stock logo
SSL
Sasol
semi-annual$0.52486.9%3/14/20243/15/20243/29/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
CEY
VictoryShares Emerging Market High Div Volatility Wtd ETF
N/AN/AN/A
ELD
WisdomTree Emerging Markets Local Debt Fund
N/AN/AN/A
Sasol Limited stock logo
SSL
Sasol
N/AN/AN/A
10x Genomics, Inc. stock logo
TXG
10x Genomics
N/A
5.22
4.45

Ownership

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
CEY
VictoryShares Emerging Market High Div Volatility Wtd ETF
N/A500,000N/ANot Optionable
ELD
WisdomTree Emerging Markets Local Debt Fund
N/A3.00 millionN/ANot Optionable
Sasol Limited stock logo
SSL
Sasol
29,073634.34 million627.99 millionOptionable
10x Genomics, Inc. stock logo
TXG
10x Genomics
1,259119.17 million106.48 millionOptionable

CEY, SSL, TXG, and ELD Headlines

SourceHeadline
Cathie Woods Latest Buys: 3 Stocks the ARK Invest CEO Cant Get Enough OfCathie Wood's Latest Buys: 3 Stocks the ARK Invest CEO Can't Get Enough Of
investorplace.com - May 6 at 1:04 PM
International Markets and 10x Genomics (TXG): A Deep Dive for InvestorsInternational Markets and 10x Genomics (TXG): A Deep Dive for Investors
zacks.com - May 6 at 10:11 AM
Vestmark Advisory Solutions Inc. Makes New $4.33 Million Investment in 10x Genomics, Inc. (NASDAQ:TXG)Vestmark Advisory Solutions Inc. Makes New $4.33 Million Investment in 10x Genomics, Inc. (NASDAQ:TXG)
marketbeat.com - May 4 at 2:39 PM
Research Analysts Issue Forecasts for 10x Genomics, Inc.s Q2 2024 Earnings (NASDAQ:TXG)Research Analysts Issue Forecasts for 10x Genomics, Inc.'s Q2 2024 Earnings (NASDAQ:TXG)
americanbankingnews.com - May 4 at 1:42 AM
Q2 2024 Earnings Estimate for 10x Genomics, Inc. Issued By William Blair (NASDAQ:TXG)Q2 2024 Earnings Estimate for 10x Genomics, Inc. Issued By William Blair (NASDAQ:TXG)
marketbeat.com - May 3 at 7:28 AM
10x Genomics (NASDAQ:TXG) PT Lowered to $36.0010x Genomics (NASDAQ:TXG) PT Lowered to $36.00
americanbankingnews.com - May 3 at 5:14 AM
10x Genomics (NASDAQ:TXG) Stock Rating Lowered by TD Cowen10x Genomics (NASDAQ:TXG) Stock Rating Lowered by TD Cowen
americanbankingnews.com - May 3 at 5:14 AM
The Goldman Sachs Group Lowers 10x Genomics (NASDAQ:TXG) Price Target to $26.00The Goldman Sachs Group Lowers 10x Genomics (NASDAQ:TXG) Price Target to $26.00
americanbankingnews.com - May 3 at 5:14 AM
Stifel Nicolaus Lowers 10x Genomics (NASDAQ:TXG) Price Target to $53.00Stifel Nicolaus Lowers 10x Genomics (NASDAQ:TXG) Price Target to $53.00
americanbankingnews.com - May 3 at 5:14 AM
10x Genomics (NASDAQ:TXG) PT Lowered to $30.0010x Genomics (NASDAQ:TXG) PT Lowered to $30.00
americanbankingnews.com - May 3 at 5:14 AM
10x Genomics to Present at the BofA Securities 2024 Healthcare Conference10x Genomics to Present at the BofA Securities 2024 Healthcare Conference
prnewswire.com - May 2 at 4:05 PM
TD Cowen Downgrades 10x Genomics (TXG)TD Cowen Downgrades 10x Genomics (TXG)
msn.com - May 2 at 7:37 AM
10x Genomics First Quarter 2024 Earnings: In Line With Expectations10x Genomics First Quarter 2024 Earnings: In Line With Expectations
finance.yahoo.com - May 2 at 7:37 AM
10x Genomics, Inc: 10x Genomics Reports First Quarter 2024 Financial Results10x Genomics, Inc: 10x Genomics Reports First Quarter 2024 Financial Results
finanznachrichten.de - May 2 at 2:37 AM
10x Genomics (NASDAQ:TXG) Sets New 12-Month Low After Analyst Downgrade10x Genomics (NASDAQ:TXG) Sets New 12-Month Low After Analyst Downgrade
americanbankingnews.com - May 2 at 1:18 AM
10x Genomics (NASDAQ:TXG) Given New $30.00 Price Target at UBS Group10x Genomics (NASDAQ:TXG) Given New $30.00 Price Target at UBS Group
marketbeat.com - May 1 at 2:32 PM
10x Genomics (NASDAQ:TXG) Hits New 12-Month Low After Analyst Downgrade10x Genomics (NASDAQ:TXG) Hits New 12-Month Low After Analyst Downgrade
marketbeat.com - May 1 at 11:34 AM
Analysts’ Opinions Are Mixed on These Healthcare Stocks: 10x Genomics (TXG), Zoetis (ZTS) and Blueprint Medicines (BPMC)Analysts’ Opinions Are Mixed on These Healthcare Stocks: 10x Genomics (TXG), Zoetis (ZTS) and Blueprint Medicines (BPMC)
markets.businessinsider.com - May 1 at 8:41 AM
10x Genomics (NASDAQ:TXG) Downgraded by TD Cowen10x Genomics (NASDAQ:TXG) Downgraded by TD Cowen
marketbeat.com - May 1 at 8:32 AM
Canaccord Genuity Group Lowers 10x Genomics (NASDAQ:TXG) Price Target to $50.00Canaccord Genuity Group Lowers 10x Genomics (NASDAQ:TXG) Price Target to $50.00
americanbankingnews.com - May 1 at 5:32 AM
10x Genomics Inc (TXG) (Q1 2024) Earnings Call Transcript Highlights: Diverse Revenue Streams ...10x Genomics Inc (TXG) (Q1 2024) Earnings Call Transcript Highlights: Diverse Revenue Streams ...
finance.yahoo.com - May 1 at 3:41 AM
Curio Bioscience Reports Clarifying Decision From European Unified Patent Court (UPC)Curio Bioscience Reports Clarifying Decision From European Unified Patent Court (UPC)
businesswire.com - May 1 at 1:01 AM
10x Genomics: Q1 Earnings Snapshot10x Genomics: Q1 Earnings Snapshot
sfgate.com - April 30 at 10:41 PM
TXG Stock Earnings: 10x Genomics Meets EPS, Misses Revenue for Q1 2024TXG Stock Earnings: 10x Genomics Meets EPS, Misses Revenue for Q1 2024
markets.businessinsider.com - April 30 at 10:41 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

VictoryShares Emerging Market High Div Volatility Wtd ETF

NYSEARCA:CEY

WisdomTree Emerging Markets Local Debt Fund

NYSEARCA:ELD
The WisdomTree Emerging Markets Local Debt Fund (ELD) is an exchange-traded fund that mostly invests in broad credit fixed income. The fund is actively managed and invests in both investment- and non-investment-grade government and corporate bonds from emerging countries denominated in local currencies. ELD was launched on Aug 9, 2010 and is managed by WisdomTree.
Sasol logo

Sasol

NYSE:SSL
Sasol Limited operates as an integrated chemical and energy company in South Africa. It offers alumina, such as battery materials, catalyst supports, abrasives and polishing, and polymer additives; cobalt fischer-tropsch; carbon-based products; recarburiser; graphite electrodes; mono-ethylene glycol, ethylene, propylene, sasfroth blends, sodium cyanide, caustic soda, hydrochloric acid, sulfuric acid, calcium chloride, chlorine, alcohols, aromatic blends, methyl alcohol, polyethylene, polypropylene, polyvinyl chloride, cresols, xylenols, phenols, limestone ammonium nitrate, ammonium nitrate solution, and nitric acid. The company also provides linear alkyl benzene, sulfonate, fatty alcohols, alkoxylates, ether sulfates, solvents, dispersants, diluents esters, macrogol/PEG, AHA esters, waxes, dispersants, diluents, ethanol, isopropyl, acetone, MIBK and ethyl acetate, C6-C20+ and guerbet alcohols, ethoxylates, propoxylates, carboxylates, sulfates, sulfonates, LAS salts, paraffins, and ethylene oxide. In addition, it offers alcohols, esters, ethers, carboxylic acids, surfactants, oil and water soluble polyglycols, formulation and surface modifiers, solvents and coalescents, wax cuts, blends and forms, FT hard waxes, waxes and blends, lubrication packages, plasticizers, nucleators, release agents, emulsifiers, dispersants, wetting agents, tank-mix adjuvant components, fertiliser additives, specialty solvents, specialty grade acetone, MEK, various ethanol blends, n and i-propanol and butanol, various C4+ alcohols, ethyl and butyl acrylate monomers, octene, hexene, and pentene. Further, it explores, develops, produces, markets, and distributes natural oil and gas, and associated products; markets fuels and lubricants; develops lower-carbon energy solutions; operates coal mines; trades and transports oil, petrochemicals, and chemical products and derivatives; and provides engineering services. Sasol Limited was founded in 1950 and is based in Johannesburg, South Africa.
10x Genomics logo

10x Genomics

NASDAQ:TXG
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium, chromium connect, and chromium controller instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity and networks on a cell-by-cell basis; single cell gene expression flex; single cell immune profiling used to study the immune system; single cell Assay for Transposase Accessible Chromati (ATAC) solution to understand the epigenetic state; and single cell multiome ATAC + gene expression which enables simultaneous interrogation of both the RNA and chromatin accessibility, using ATAC in a single cell. The company also provides Visium platform which enables researchers to understand the spatial positions of biological analytes within tissues at high resolution; and Xenium platform for in situ analysis. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.